SCHEMBL10041278

SCHEMBL10041278

CC(C)(C)c1nc2ccccc2n1-c1cccc(-n2c(C(C)(C)C)nc3ccccc32)c1C#N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
CNR2 P34972 2/20 0.40
KDM4E B2RXH2 5/20 0.40
ALDH1A1 P00352 5/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
MAPT P10636 3/20 0.39
NPSR1 Q6W5P4 3/20 0.39
POLB P06746 2/20 0.39
GAA P10253 2/20 0.39
GLA P06280 1/20 0.39
XBP1 P17861 1/20 0.39
SLC22A12 Q96S37 3/20 0.39
TP53 P04637 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KMT2A Q03164 1/20 0.38
MAPK1 P28482 2/20 0.38
KLK7 P49862 1/20 0.38
RPS6KB1 P23443 1/20 0.38
ROCK1 Q13464 1/20 0.38
HIF1A Q16665 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10041282 0.88 SLC22A12 (0.41) TSHRCNR2KDM4EALDH1A1SMN1; SMN2
SCHEMBL10041280 0.84 MAPK1 (0.41) TSHRKDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL25878270 0.79 CNR2 (0.54) TSHRCNR2KDM4EALDH1A1SMN1; SMN2
SCHEMBL14124486 0.79 TSHR (0.45) TSHRCNR2KDM4EALDH1A1SMN1; SMN2
SCHEMBL14124469 0.79 TSHR (0.45) TSHRCNR2KDM4EALDH1A1SMN1; SMN2
SCHEMBL10041277 0.78 MAPK1 (0.48) TSHRCNR2KDM4EALDH1A1MAPT
SCHEMBL10041271 0.78 TSHR (0.42) TSHRCNR2KDM4EALDH1A1SMN1; SMN2
SCHEMBL12679893 0.77 KDM4E (0.40) TSHRCNR2KDM4EALDH1A1SMN1; SMN2
SCHEMBL63683 0.76 SLC22A12 (0.46) TSHRCNR2KDM4EALDH1A1SMN1; SMN2
SCHEMBL10041261 0.75 CNR2 (0.46) TSHRCNR2KDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8147987-B2 Organic electroluminescent element and compounds for use in the element FUJIFILM CORPORATION (JP) 2012-04-03 US disclosed
US-8147987-B2 Organic electroluminescent element and compounds for use in the element FUJIFILM CORPORATION (JP) 2012-04-03 US disclosed
US-20070202357-A1 Organic electroluminescent element and compounds for use in the element FUJIFILM CORPORATION (JP) 2007-08-30 US disclosed
US-20070202357-A1 Organic electroluminescent element and compounds for use in the element FUJIFILM CORPORATION (JP) 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070202357-A1 Organic electroluminescent element and compounds for use in the element RPL31, RPL38, RPL39 TSHR 1844/4885CNR2 3289/4885KDM4E 2859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.